baber/WOPTO huggingface dataset:
Patent EA-000751-B1 (EA)
Title: Aluminothermic mixture
Inventor: FROMMEYER GEORG
IPC: B23K23/00
Filed: 1996-11-14
Abstract: 1 An aluminothermic mixture consisting of a finely particulate base portion of a thermic mixture comprising iron oxides and aluminum as well as metallic additives, wherein pure iron and alloying components Fe, Cr, Si and C and, if necessary, metals-modifiers are added to the base portion as metallic additives. 2. The aluminothermic mixture as claimed in claim 1, wherein the metallic additives comprise pure iron and a master alloy of FeCrSiC and, if necessary, metals-modifiers. 3. The aluminothermic mixture as claimed in claim 1 or 2, wherein the metallic additives are added in a quantity providing formation of perlitic structure in steel produced by said aluminothermic process. 4. The aluminothermic mixture as claimed in claim 1 or 2, wherein the metallic additives are added in a quantity providing formation of perlitic structure consisting of troostite/sorbite in a combination with granular morphology of the upper intermediate layer in steel produced by said aluminothermic process. 5. The aluminothermic mixture as claimed in claim 1 to 4, wherein the metallic additives are added in a quantity of from 15 to 30% by weight, relative to the base portion of the thermic mixture. 6. The aluminothermic mixture as claimed in claim 1 to 4, wherein 5 to 10% by weight of master alloy and 10 to 20% by weight of pure iron, each relative to the base portion of the thermic mixture, are added as metallic additives. 7. The aluminothermic mixture as claimed in claim 1 to 6, wherein a master alloy  consisting of (in % by weight) FeCr 15-50 Si 5-20 Si 5-20 CO,5-8, preferably FeCr 25-40 Si 10-15 C 1,5-4,5.
Patent EA-002088-B1 (EA)
Title: Fungicidal mixture
Inventor: SCHELBERGER KLAUS
IPC: A01N47/24
Filed: 1998-05-13
Abstract: 1. A fungicidal mixture comprising synergistically effective amounts of  a) a phenyl benzyl ether derivative of formula I.a, I.b and I.c,      and or carbamate of formula I.d   where X is CH or N, n is 0, 1 or 2 and R is halogen, C1-C4 alkyl or C1-C4 haloalkyl, it being possible for the radicals R to be different if n is 2, or a salt or adduct thereof, and (b) a N-acetonylbenzamide of the formula II   in which the substituents have the following meaning: R<1> and R<3> independently of one another are each halogen or C1-C4 alkyl; R<2> is cyano, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl or C1-C4 alkoxy; R<4> is hydrogen or C1-C4 alkyl; R<5> is C2-C4 alkyl; R<6> is thiocyano, isothiocyano or halogen, or a salt or adduct thereof. 2. The fungicidal mixture of claim 1, wherein a weight ratio of compound I to compound II or its salt or adduct is from 10:1 to 0.01:1. 3. A method for controlling harmful fungi, which comprises treating the harmful fungi, their habitat, or plants, seeds, soils, areas, materials or spaces are treated with a compound of formula I of claim 1 and a compound of formula II, correspondingly, with its salt or adduct. 4. The method of claim 3, wherein the compound I of claim 1 and the compound II, correspondingly, its salt or adduct of claim 1 are applied simultaneously, separately or together, or in succession. 5. The method of claim 3 or 4, wherein the compound I is applied in an amount of from 0.01 to 2.5 kg/ha. 6. The method of claim 3 or 5, wherein the compound II, correspondingly its salt or adduct is applied in an amount of from 0.01 to 10 kg/ha. 7. Use of a compound I of claim 1 for preparing a fungicidal synergistically effective mixture of claim 1. 8. Use of a compound II, correspondingly its salt or adduct of claim 1 for preparing a fungicidal synergistically effective mixture of claim 1. 9. The composition defined in claim 1 which is conditioned in two parts, one part comprising the compound I of claim 1 in a solid or liquid carrier and the other part comprising the compound II, correspondingly its salt or adduct of claim 1 in a solid or liquid carrier.
Patent EA-003821-B1 (EA)
Title: Twisted wire structure
Inventor: BURJUKOV BORIS ALEXANDROVICH
IPC: D07B1/08
Filed: 2002-04-22
Abstract: 1. A twisted-wire structure, consisting of two elements, one of which is a strand comprising m number of wires connected by a spiral lay, and a second element comprising n number of wires connected to the strand by a spiral lay, characterized in that both elements are connected by a spiral lay so that the strand wires project between winding n ( m + 2 wires of an outer wire winding alternating them along the length of each lay pitch, while the longitudinal axis of the brand bending around spirally the longitudinal axis of the twisted structure. 2. The twisted wire structure of claim 1, characterized in that its section is designed of two and more element pairs, and each pair comprises a strand of m wires and the outer wire winding n ( m + 2 wires.
Patent EA-005930-B1 (EA)
Title: Pharmaceutical composition based on pyridoindolone derivatives and anticancer agents
Inventor: BOURRIE BERNARD
IPC: A61K45/06
Filed: 2002-04-26
Abstract: The invention concerns the combination of compounds of formula (I) with several anticancer agents.
Patent EA-006724-B1 (EA)
Title: Process for producing liquid natural gas (variants)
Inventor: FISCHER-CALDERONE ERNESTO
IPC: F25J1/00
Filed: 2002-12-18
Abstract: The present invention is directed to a process for producing LNG by directing a feed stream (11) comprising natural gas to a cooling stage that a cools the feed stream in at least one cooling step (12) producing a cooled feed stream (13), b expands the cooled feed stream in at least one expansion step (14) by reducing the pressure of the cooled feed stream producing a refrigerated vapor component and a liquid component, and c separates (16) at least a portion of the refrigerated vapor component (18, 21) from the liquid component (17) wherein at least a portion of the cooling for the process is derived from at least a portion of the refrigerated vapor component (18) and repeating steps a through c one or more times until at least substantial portion of the feed stream in the first cooling stage is processed into LNG (37) wherein the feed stream in step a comprises at least a portion of the liquid component produced from a previous cooling stage.
Patent EA-006514-B1 (EA)
Title: Turnaround table for conducting modified orthostatic test
Inventor: SNEZHITSKY VIKTOR ALEXANDROVIC
IPC: A61B5/0452
Filed: 2004-08-06
Abstract: The invention relates to medicine, in particular to cardiology and can be used for diagnosis disfunction of autonomous nervous system in patients with pathology of sinus node and syncopal states caused by parasympathotonia. The invention task is to develop a device for safety taking functional test changing the patient's body position enabling to conduct dynamic studies of cardiac function indices under continuos direction change of the turnover table. The inventive task is solved by using a turnover table for conducting modified orthostatic test comprises a frame, a lying surface with a support for legs, an electric motor, a V-belt transmission, a worm reduction gearbox, gears, toothed sectors marked in degrees between 0-60 degree for selecting inclination of the lying surface, wherein the angular velocity of the lying surface turn is 6 degrees/sec, the turnover table further comprises a shaft, bearing supports, adjustable rests, a spring-loaded support and a control board, besides the turnover table is provided with an electrical circuit comprising contactless switches, intermediate relays and time relays, proximity sensors, the lying surface of the table is provided with a retaining and fixing belt.
Patent EA-008034-B1 (EA)
Title: Ash-protection inlet fitting for vertical tubes of heat transfer tube bunch
Inventor: LAFA JURIJ IVANOVICH
IPC: F28F9/00
Filed: 2005-06-28
Abstract: The invention relates to boilers and provides protection against abrasion wear in coal-fired boilers caused by abrasive ash when it passes through vertical heat-exchanging tubes resulting in tube wall erosion and reducing the tube lifetime. An ash protection inlet fitting for vertical heat-exchanging tubes comprises a cellular element for the each tube, the walls of these cellular elements are adjacent and attached to each other in the adjacent points. Each cellular element is connected by a transition section to a stabilizing section, which is aligned with a connecting section that is inserted into an appropriate heat-exchanging tube. Each cellular element contains a thin-walled mesh grid.
Patent EA-009269-B1 (EA)
Title: Bill handling device and control system thereof
Inventor: YOSHIOKA KAZUEI
IPC: G07D11/00
Filed: 2006-06-16
Abstract: There is provided a bill handling device in which the size of the device can be reduced by disposing various component members in a limited amount of installation space in a space-efficient manner and efficient bill collection is further realized. The bill handling device includes a bill transport mechanism for transporting a bill inserted from a bill insertion slot along the insertion direction and ejecting the bill toward a bill push area located downstream of the bill transport mechanism; a press plate provided on one side of a housing and pressing the bill ejected in the bill push area toward the other side; a stacking tray reciprocally movable along the insertion direction and stacking and storing the bill pressed by the press plate; a stacking tray drive mechanism for reciprocally moving the stacking tray; a shutter mechanism having a shutter, the shutter mechanism opening and closing the shutter through which the front end area of the stacking tray can project. The stacking tray holds the bill such that when the front end portion of the stacking tray projects from the housing through the shutter, the front end portion of the stacked and stored bill is exposed.
Patent EA-010578-B1 (EA)
Title: Antiviral preparation based on insect hemolymph of pterigota subclass
Inventor: CHERNYSH SERGEY IVANOVICH
IPC: A61K35/63
Filed: 2004-12-30
Abstract: The invention relates to pharmacologically-active preparations of native origin and can be used for preparing antiviral drugs and treating viral infections. The aim of the invention is to extend considerably a range of antiviral drugs increasing viral infection resistance based on insect hemolymph of Pterigota subclass due to producing a novel group of antiviral drugs – direct action antiviral drugs obtained by extraction from insect tissues of different insect Orders used as entoviron sources. Said drugs, experimentally tested, implicate individual substances or mixtures thereof, which increase resistance of organism cells towards viral infection by destruction of virus, blockage of replication thereof or by other way, which can run aside from immune system.
Patent EA-011562-B1 (EA)
Title: Method and advice for improving perceptibility different structures on radiographs
Inventor: THOMS MICHAEL
IPC: A61B6/00
Filed: 2004-07-27
Abstract: The invention relates to a method for improving the perceptibility of different structures (18) on radiographs (10) by means of an image processing device (20) consisting a) in storing a radiograph (10) in electronic form as a local space-intensity distribution, b) in carrying out a Fourier transformation for determining a frequency-intensity distribution, c) in filtering said frequency-intensity distribution by modifying weighting between the high-frequency and low-frequency image signal components, wherein the fixing of the image signal components to be more intensively weighted is carried out taking into account the mean structure size of said structures whose perceptibility is to be improved, d); in carrying out an inverse Fourier transformation of the filtered frequency-intensity distribution in order to obtain a modified space-intensity distribution in which said structures are more easily perceptible. The image contrast for the hardly perceptible structures may be selectively improved by means of a changed weighting for the high-frequency, relative to the low-frequency, image signal components in the Fourier spectrum because the structures hardly perceptible on the radiographs, for example soft tissue parts having a size quantity and structuring different from easily perceptible structures as bones and implantants.
Patent EA-012058-B1 (EA)
Title: Catalytic reactor
Inventor: BOWE MICHAEL JOSEPH
IPC: C01B3/38
Filed: 2006-01-11
Abstract: A compact catalytic reactor for Fischer-Tropsch synthesis (50) comprises a reactor module (70) defining a multiplicity of first and second flow channels arranged alternately, for carrying a gas mixture, and a coolant respectively. A removable gas-permeable catalyst structure (82) with a substrate for example of metal foil is provided in each flow channel in which the synthesis reaction is to occur. The reactor module (70) is enclosed within a pressure vessel (90), the pressure within the pressure vessel being arranged to be at a pressure substantially that of the high pressure reacting gas mixture. Consequently all the flow channels within the module are either at the pressure of their surroundings, or are under compression; no parts are under tension. This simplifies the design of the module, and increases the proportion of reactor volume which can be occupied by the catalyst.
Patent EA-012489-B1 (EA)
Title: Protection of solid acid catalyst by volatile species
Inventor: VOSKOBOYNIKOV TIMUR V
IPC: C01B3/26
Filed: 2006-06-26
Abstract: The invention provides a method to avoid catalyst damage and achieve longer catalyst life by selecting appropriate materials for reactor spacers, liners, catalyst binders, and supports, in particular, by not using crystalline silica-containing and high phosphorus-containing materials, if the presence of even small amount of steam is anticipated. In addition, alkali metals and alkaline earth metals are avoided due to potential damage to the catalyst.
Patent EA-014244-B1 (EA)
Title: METHOD FOR1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
Inventor: KREPSKI LARRY R
IPC: C07D213/82
Filed: 2006-09-22
Abstract: Methods and intermediates for preparing compounds of the Formulas: (I and X) are disclosed. The methods include a method providing a compound of the Formula: (IV) and converting a compound of Formula IV to a compound of Formula I, a method providing a compound of the Formula: (VIII) and converting a compound of Formula VIII to a compound of Formula I, and a method providing a compound of the Formula: (XI) and converting a compound of Formula XI to a compound of Formula I.
Patent EA-015656-B1 (EA)
Title: Composition and method for improved aluminum hydroxide production
Inventor: LIU JIANJUN
IPC: C01F7/145
Filed: 2007-05-14
Abstract: An improved method and composition for producing aluminum hydroxide crystals in a Bayer process pregnant liquor, involve the addition of an emulsified crystallization modifier comprising a C8-C10 fatty acid, precursors, salts or blends thereof. The alkyl chain of the fatty acid crystallization modifier is free of functional groups. The modifier yields a commercially viable product in the presence and absence of a hydrocarbon oil which dissolves the fatty acid. Further, the modifier, prepared in either an emulsified form or as a fatty acid neat, facilitates formation of oxalate aggregates greater than 200 [mu]m which may be readily screened out with minimum trihydrate loss.
Patent EA-023936-B1 (EA)
Title: Low-viscosity aqueous adhesive polymer dispersions
Inventor: ACHTEN DIRK
IPC: C09J111/02
Filed: 2008-08-09
Abstract: The invention relates to low-viscosity aqueous polymer dispersions low in monomers and based on polychloroprene and to a method for the production thereof and the use thereof as contact adhesive.
Patent EA-019784-B1 (EA)
Title: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
Inventor: RODGERS JAMES D
IPC: A61K31/519
Filed: 2008-06-12
Abstract: The present invention provides salt forms of (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that are useful in the modulation of Janus kinase activity and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Patent EA-021623-B1 (EA)
Title: Supported catalyst and method for producing an amine
Inventor: KUBANEK PETR
IPC: C07C211/16
Filed: 2010-11-29
Abstract: The invention relates to a supported catalyst, comprising copper, nickel and cobalt for aminating primary or secondary alcohol, aldehyde and/or ketone and to a method for producing an amine by reacting a primary or secondary alcohol, aldehyde and/or ketone with hydrogen and a nitrogen compound, selected from the group containing ammonia, primary and secondary amines, in the presence of a supported catalyst that contains copper, nickel and cobalt, the catalytically active mass of the catalyst, prior to the reduction of the same using hydrogen, containing oxygen-containing compounds of aluminium, copper, nickel and cobalt and 0.2 to 5.0 wt.% of oxygen-containing compounds of tin, calculated as SnO.
Patent EA-024771-B1 (EA)
Title: Method for rapid laboratory diagnostics of diseases based on identification of specific proteins
Inventor: MARTYNOV ARTUR VIKTOROVICH
IPC: G01N33/543
Filed: 2010-11-22
Abstract: The invention can be used in medicine and veterinary to create test-systems for diagnostics of various diseases, for which unique proteins or change of their concentration serve as markers. Essence of the invention: the method for rapid laboratory diagnostics of diseases, based on identification of characteristic for disease specific target proteins in reaction of their specific interaction with other reagent proteins is characterised by the fact that specific for the disease target protein is taken, hydrolysed with proteolytic enzymes, chemical structure of formed composition of oligopeptides is modified in such a way that their charge changes to the opposite with the following use as reagent proteins instead of specific immunoglobulins in method of immunofluorescence and immune enzyme method. The method can be applied for identification of viral antigens, microbial antigens in various human biological fluids as well as for detection of novel and poorly studied infectious diseases due to simplicity of obtaining diagnosticums.
Patent EA-027351-B1 (EA)
Title: Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
Inventor: TASLER STEFAN
IPC: A61K31/422
Filed: 2012-01-27
Abstract: The present invention relates to compounds of the general formula (I)and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents.
Patent EA-031697-B1 (EA)
Title: Taste-masked pharmaceutical formulation having accelerated onset of action
Inventor: STECKEL HARTWIG
IPC: A61K47/10
Filed: 2011-06-24
Abstract: Pharmaceutical composition for dissolution in the mouth comprises from about 10 to about 150 parts by weight of sildenafil citrate, from about 50 to about 600 parts by weight of isomalt and from about 2 to about 100 parts by weight of sodium hydrogen carbonate as pharmaceutical excipients and a pharmaceutically acceptable organic acid, wherein sildenafil citrate and isomalt are present as a powder mixture or as a compacted tablet powder mixture and wherein a weight ratio isomalt:sildenafil citrate is from about 3:1 to about 12:1. The above composition for treating male erectile dysfunction is also disclosed.
Patent EA-034182-B1 (EA)
Title: Method for the treatment of cancer using bispecific antibodies against cd3 and dll3
Inventor: HUDSON LINDSEY JANE
IPC: C07K16/30
Filed: 2014-02-12
Abstract: The provided invention relates to a method for the treatment of cancer, such as lung cancer, pancreatic cancer and skin cancer, which comprises administering to a subject in need thereof a therapeutically effective amount of a bispecific antibody which binds to DLL3 and CD3.
Patent EA-035745-B1 (EA)
Title: Cysteine residues engineered fibronectin type iii domain binding molecules
Inventor: GOLDBERG SHALOM
IPC: A61K38/22
Filed: 2014-10-13
Abstract: Cysteine residues engineered monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules comprising one or more free cysteine amino acids are prepared by mutagenizig a nucleic acid sequence of a parent molecule and replacing one or more amino acid residues by cysteine to encode the cysteine residues engineered FN3 domain containing monospecific or bispecific molecules; expressing the cysteine engineered FN3 domain containing molecules; and recovering the cysteine engineered FN3 domain containing molecule. An isolated cysteine engineered monospecific or bispecific FN3 domain containing molecule may be covalently attached to a detection label or a drug moiety and used therapeutically.
Patent EA-033204-B1 (EA)
Title: Process for the production of synthesis gas
Inventor: WIX CHRISTIAN
IPC: C01B3/38
Filed: 2014-12-11
Abstract: Process for the production of a synthesis gas for use in the production of chemical compounds from a hydrocarbon feed stock containing higher hydrocarbons comprising the following steps: (a) in a pre-reforming stage pre-reforming the feed stock with steam to a pre-reformed gas containing methane, hydrogen, carbon monoxide and carbon dioxide; (b) cooling the pre-reformed gas to below its dewpoint and removing condensed water; (c) reducing the amount of carbon dioxide the in the pre-reformed gas from step (b) by means of a chemical wash or physical carbon dioxide separation to obtain a module of (H-CO)/(CO+CO) of between 1.0 and 3.8 in the pre-reformed gas; and d) feeding the pre-reformed gas from step (c) in a steam reforming stage comprising a tubular steam reformer or an autothermal reformer or a primary steam reformer and a subsequent secondary steam reformer to obtain a synthesis gas; wherein the higher hydrocarbons contained in the hydrocarbon feed stock are hydrocarbons heavier than methane.
Patent EA-032358-B1 (EA)
Title: Treatment of intrahepatic cholestatic diseases
Inventor: BOUDES POL
IPC: A61P1/16
Filed: 2015-03-19
Abstract: The present invention relates to a method of treating an intrahepatic cholestatic disease comprising administering a compound which is (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof. The compound may be (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid L-Lysine dihydrate salt. The compound may be administered orally in a dose 20-200 mg/day, the dose of the compound being calculated as (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid. The intrahepatic cholestatic disease is primary biliary cirrhosis, primary sclerosing cholangitis, progressive familial intrahepatic cholestasis or Alagille syndrome.